Published in Medical Devices and Surgical Technology Week, August 22nd, 2004
Eps from normal operations for the most recent four calendar quarters (LTM) were $1.51. Including "extraordinary" income from 4Q 2003 and 1Q 2004, LTM eps were $4.93. The extraordinary income results from receipt of Tyco International damages and interest of $30,944,000 relating to patent infringement.
UTMD's 2Q 2004 sales were about the same as 2Q 2003, a recovery from 1Q 2004 when sales were down 4% compared to 1Q 2003. Combining the two quarters, 1H 2004 sales...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.